-
公开(公告)号:US20060004101A1
公开(公告)日:2006-01-05
申请号:US11165217
申请日:2005-06-24
申请人: Kiwamu Okita , Isao Sakaida , Yoshihiro Morinaga , Shoji Fujitani
发明人: Kiwamu Okita , Isao Sakaida , Yoshihiro Morinaga , Shoji Fujitani
IPC分类号: A61K31/198
CPC分类号: A23L1/3051 , A23K20/142 , A23L33/175 , A23V2002/00 , A61K31/198 , A61K2300/00 , A23V2250/0626 , A23V2250/0628 , A23V2250/0654
摘要: The present invention provides a prophylactic or therapeutic agent, a pharmaceutical composition and a health-promoting food, which are used for human or other animal for the inhibition of the onset or progress of liver cancer, namely, an inhibitor of the onset or progress of liver cancer, which contains isoleucine, leucine and valine as active ingredients, wherein the weight ratio of isoleucine, leucine and valine is preferably 1:1.5 to 2.5:0.8 to 1.7 and the daily dose is 2.0 g to 50.0 g.
摘要翻译: 本发明提供了用于人或其他动物用于抑制肝癌的发病或进展的预防或治疗剂,药物组合物和促进健康的食物,即抑制剂的发病或进展的抑制剂 含有异亮氨酸,亮氨酸,缬氨酸作为活性成分的肝癌,其中异亮氨酸,亮氨酸,缬氨酸的重量比优选为1:1.5〜2.5:0.8〜1.7,日剂量为2.0g〜50.0g。
-
公开(公告)号:US09271521B2
公开(公告)日:2016-03-01
申请号:US11165217
申请日:2005-06-24
申请人: Kiwamu Okita , Isao Sakaida , Yoshihiro Morinaga , Shoji Fujitani
发明人: Kiwamu Okita , Isao Sakaida , Yoshihiro Morinaga , Shoji Fujitani
IPC分类号: A61K31/198 , A23L1/305 , A61P1/16 , A23K1/16
CPC分类号: A23L1/3051 , A23K20/142 , A23L33/175 , A23V2002/00 , A61K31/198 , A61K2300/00 , A23V2250/0626 , A23V2250/0628 , A23V2250/0654
摘要: The present invention provides a prophylactic or therapeutic agent, a pharmaceutical composition and a health-promoting food, which are used for human or other animal for the inhibition of the onset or progress of liver cancer, namely, an inhibitor of the onset or progress of liver cancer, which contains isoleucine, leucine and valine as active ingredients, wherein the weight ratio of isoleucine, leucine and valine is preferably 1:1.5 to 2.5:0.8 to 1.7 and the daily dose is 2.0 g to 50.0 g.
-